Warsaw, Poland: The European Alliance for Personalised Medicine’s (EAPM) latest SMART Outreach meeting in Warsaw, Poland (1-2 March) found consensus with the Polish Alliance for Personalised Medicine on several vital issues, not least patient access and the need for more and better research.

Public consultation on Notice from the Commission on aspects of the application of Article 3, 5 and 7 of Regulation (EC) N° 141/2000 on orphan medicinal products

Strasbourg, 4 February: This week, on 4 February to be exact, sees World cancer Day 2016, and it seems that, according to the World Health Organization, new cases of cancer globally are expected to increase by 70% over the next 20 years, from around 14 million to 25m. 

European Parliament, Strasbourg: December 16th:  Details of the General Data Protection Regulation are about to be made public and the Brussels-based European Alliance for Personalised Medicine (EAPM) welcomes the inclusion of many suggestions and recommendations it has made during the process. 

The Alliance has contributed hugely to a piece of legislation that saw around 4,000 amendments to the original draft as it developed and changed.   Now the ‘trilogue’  of European Parliament, Council and Commission have reached agreement and its impact in the arena of health, and especially health research, will be immense.